Ganirelix is a competitive and selective gonadotropin releasing hormone (GnRH) antagonist. Ganirelix prevents endogenous GnRH from inducing luteinising hormone (LH) and follicle stimulating hormone release. Ganirelix counteracts Prostaglandin E2 (HY-101952)-induced detrusor overactivity, enhances Carbachol (HY-B1208)-induced detrusor contractions. Ganirelix can be used for the research of female infertility and detrusor overactivity[1][2][3].
Molekulargewicht:
1570.32
Reinheit:
99.88
CAS Nummer:
[124904-93-4]
Formel:
C80H113ClN18O13
Target-Kategorie:
GnRH Receptor
Anwendungsbeschreibung:
MCE Product type: Peptides
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten